Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Next-generation Sequencing (NGS) Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Next-generation Sequencing (NGS) Market, by Product, 2020-2028 (USD Billion)
1.2.3. Global Next-generation Sequencing (NGS) Market, by Technology, 2020-2028 (USD Billion)
1.2.4. Global Next-generation Sequencing (NGS) Market, by Application, 2020-2028 (USD Billion)
1.2.5. Global Next-generation Sequencing (NGS) Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Next-generation Sequencing (NGS) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Next-generation Sequencing (NGS) Market Dynamics
3.1. Next-generation Sequencing (NGS) Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Developments in NGS platforms
3.1.1.2. Rising prevalence of cancer and increasing applications of next-generation sequencing in cancer research
3.1.2. Market Challenges
3.1.2.1. Interpretation of complex data from NGS platforms
3.1.2.2. Emergence of alternative technologies
3.1.3. Market Opportunities
3.1.3.1. Government & private support for large-scale sequencing
3.1.3.2. Integration of big data in NGS data analysis
Chapter 4. Global Next-generation Sequencing (NGS) Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Next-generation Sequencing (NGS) Market, by Product
6.1. Market Snapshot
6.2. Global Next-generation Sequencing (NGS) Market by Product, Performance - Potential Analysis
6.3. Global Next-generation Sequencing (NGS) Market Estimates & Forecasts by Product 2019-2028 (USD Billion)
6.4. Next-generation Sequencing (NGS) Market, Sub Segment Analysis
6.4.1. NGS Consumables
6.4.2. Sequencing Services
6.4.3. Presequencing Products & Services
6.4.4. NGS Platforms
6.4.5. Bioinformatics
6.4.6. Services for NGS Platforms
Chapter 7. Global Next-generation Sequencing (NGS) Market, by Technology
7.1. Market Snapshot
7.2. Global Next-generation Sequencing (NGS) Market by Technology, Performance - Potential Analysis
7.3. Global Next-generation Sequencing (NGS) Market Estimates & Forecasts by Technology 2019-2028 (USD Billion)
7.4. Next-generation Sequencing (NGS) Market, Sub Segment Analysis
7.4.1. Sequencing by Synthesis
7.4.2. ION Semiconductor Sequencing
7.4.3. Nanopore Sequencing
7.4.4. Single-Molecule Real-Time Sequencing
7.4.5. Other Technologies
Chapter 8. Global Next-generation Sequencing (NGS) Market, by Application
8.1. Market Snapshot
8.2. Global Next-generation Sequencing (NGS) Market by Application, Performance - Potential Analysis
8.3. Global Next-generation Sequencing (NGS) Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
8.4. Next-generation Sequencing (NGS) Market, Sub Segment Analysis
8.4.1. Diagnostics
8.4.2. Drug Discovery
8.4.3. Agricultural & Animal Research
8.4.4. Other Applications
Chapter 9. Global Next-generation Sequencing (NGS) Market, by End-User
9.1. Market Snapshot
9.2. Global Next-generation Sequencing (NGS) Market by End-User, Performance - Potential Analysis
9.3. Global Next-generation Sequencing (NGS) Market Estimates & Forecasts by End-User 2019-2028 (USD Billion)
9.4. Next-generation Sequencing (NGS) Market, Sub Segment Analysis
9.4.1. Academic Institutes & Research Centers
9.4.2. Pharmaceutical & Biotechnology Companies
9.4.3. Hospitals & Clinics
9.4.4. Other End Users
Chapter 10. Global Next-generation Sequencing (NGS) Market, Regional Analysis
10.1. Next-generation Sequencing (NGS) Market, Regional Market Snapshot
10.2. North America Next-generation Sequencing (NGS) Market
10.2.1. U.S. Next-generation Sequencing (NGS) Market
10.2.1.1. Product estimates & forecasts, 2019-2028
10.2.1.2. Technology estimates & forecasts, 2019-2028
10.2.1.3. Application estimates & forecasts, 2019-2028
10.2.1.4. End-User estimates & forecasts, 2019-2028
10.2.2. Canada Next-generation Sequencing (NGS) Market
10.3. Europe Next-generation Sequencing (NGS) Market Snapshot
10.3.1. U.K. Next-generation Sequencing (NGS) Market
10.3.2. Germany Next-generation Sequencing (NGS) Market
10.3.3. France Next-generation Sequencing (NGS) Market
10.3.4. Spain Next-generation Sequencing (NGS) Market
10.3.5. Italy Next-generation Sequencing (NGS) Market
10.3.6. Rest of Europe Next-generation Sequencing (NGS) Market
10.4. Asia-Pacific Next-generation Sequencing (NGS) Market Snapshot
10.4.1. China Next-generation Sequencing (NGS) Market
10.4.2. India Next-generation Sequencing (NGS) Market
10.4.3. Japan Next-generation Sequencing (NGS) Market
10.4.4. Australia Next-generation Sequencing (NGS) Market
10.4.5. South Korea Next-generation Sequencing (NGS) Market
10.4.6. Rest of Asia Pacific Next-generation Sequencing (NGS) Market
10.5. Latin America Next-generation Sequencing (NGS) Market Snapshot
10.5.1. Brazil Next-generation Sequencing (NGS) Market
10.5.2. Mexico Next-generation Sequencing (NGS) Market
10.6. Rest of The World Next-generation Sequencing (NGS) Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Psomagen, Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Illumina
11.2.3. Thermo Fisher Scientific
11.2.4. PerkinElmer
11.2.5. BGI Group
11.2.6. Agilent Technologies
11.2.7. Pacific Biosciences
11.2.8. Oxford Nanopore Technologies
11.2.9. QIAGEN
11.2.10. F. Hoffmann-La Roche AG
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption